Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Early Response to Corticosteroid and Baseline C-Reactive Protein Predicts Outcomes in Children with Moderate to Severe Ulcerative Colitis.

Deva Rajoo G, Tan L, Lopez A, Lewindon P, Grover Z.

Dig Dis Sci. 2019 Feb 7. doi: 10.1007/s10620-019-05486-w. [Epub ahead of print]

PMID:
30734233
2.

Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.

Chatzinasiou F, Polymeros D, Panagiotou M, Theodoropoulos K, Rigopoulos D.

Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.

PMID:
27149138
3.

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.

Armuzzi A, Pugliese D, Danese S, Rizzo G, Felice C, Marzo M, Andrisani G, Fiorino G, Nardone OM, De Vitis I, Papa A, Rapaccini GL, Guidi L.

Inflamm Bowel Dis. 2014 Aug;20(8):1368-74. doi: 10.1097/MIB.0000000000000115.

PMID:
24983979
4.

Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.

Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P.

Intern Med J. 2014 May;44(5):464-70. doi: 10.1111/imj.12397.

PMID:
24612209
5.

Early corticosteroids requirement after the diagnosis of ulcerative colitis diagnosis can predict a more severe long-term course of the disease - a nationwide study of 1035 patients.

Khan NH, Almukhtar RM, Cole EB, Abbas AM.

Aliment Pharmacol Ther. 2014 Aug;40(4):374-81. doi: 10.1111/apt.12834. Epub 2014 Jun 25.

6.

Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).

Fernández-Salazar L, Muñoz F, Barrio J, Muñoz C, Pajares R, Rivero M, Prieto V, Legido J, Bouhmidi A, Herranz M, Fernández N, Sánchez-Ocaña R, Joao D, Santos F.

Scand J Gastroenterol. 2016;51(2):186-95. doi: 10.3109/00365521.2015.1070900. Epub 2015 Jul 22.

PMID:
26200929
7.

C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study.

Iwasa R, Yamada A, Sono K, Furukawa R, Takeuchi K, Suzuki Y.

BMC Gastroenterol. 2015 Aug 14;15:103. doi: 10.1186/s12876-015-0333-z.

8.

Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study.

Beswick L, Rosella O, Rosella G, Headon B, Sparrow MP, Gibson PR, van Langenberg DR.

J Crohns Colitis. 2018 Feb 28;12(3):289-297. doi: 10.1093/ecco-jcc/jjx146.

PMID:
29121178
9.

Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.

Cucchiara S, Romeo E, Viola F, Cottone M, Fontana M, Lombardi G, Rutigliano V, de'Angelis GL, Federici T.

Dig Liver Dis. 2008 Jul;40 Suppl 2:S260-4. doi: 10.1016/S1590-8658(08)60535-6.

PMID:
18598998
10.

Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.

Duijvis NW, Ten Hove AS, Ponsioen CI, van den Brink GR, Buskens CJ, Bemelman WA, Te Velde AA, D'Haens GR, Löwenberg M.

J Crohns Colitis. 2016 Jul;10(7):821-7. doi: 10.1093/ecco-jcc/jjw031. Epub 2016 Jan 27.

PMID:
26818660
11.

Long-term outcome after infliximab for refractory ulcerative colitis.

Ferrante M, Vermeire S, Fidder H, Schnitzler F, Noman M, Van Assche G, De Hertogh G, Hoffman I, D'Hoore A, Van Steen K, Geboes K, Penninckx F, Rutgeerts P.

J Crohns Colitis. 2008 Sep;2(3):219-25. doi: 10.1016/j.crohns.2008.03.004. Epub 2008 May 16.

PMID:
21172214
12.

Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.

Halpin SJ, Hamlin PJ, Greer DP, Warren L, Ford AC.

World J Gastroenterol. 2013 Feb 21;19(7):1091-7. doi: 10.3748/wjg.v19.i7.1091.

13.

Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study.

Ma C, Beilman CL, Huang VW, Fedorak DK, Wong K, Kroeker KI, Dieleman LA, Halloran BP, Fedorak RN.

Can J Gastroenterol Hepatol. 2016;2016:2079582. doi: 10.1155/2016/2079582. Epub 2016 Jul 11.

14.

Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids.

Llaó J, Naves JE, Ruiz-Cerulla A, Marín L, Mañosa M, Rodríguez-Alonso L, Cabré E, Garcia-Planella E, Guardiola J, Domènech E.

J Crohns Colitis. 2014 Nov;8(11):1523-8. doi: 10.1016/j.crohns.2014.06.010. Epub 2014 Jul 22.

PMID:
25066954
15.

Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatments.

Barreiro-Alonso E, Saro-Gismera C, Sánchez M.

Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):733-741. doi: 10.1080/17474124.2018.1489231. Epub 2018 Jun 27.

PMID:
29911903
16.

Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.

Hyams JS, Davis S, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo P, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis A, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Britt A, Saul B, Gotman N, Wang J, Serrano J, Kugathasan S, Walters T, Denson LA.

Lancet Gastroenterol Hepatol. 2017 Dec;2(12):855-868. doi: 10.1016/S2468-1253(17)30252-2. Epub 2017 Sep 20.

17.

Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.

Aloi M, DʼArcangelo G, Bramuzzo M, Gasparetto M, Martinelli M, Alvisi P, Illiceto MT, Valenti S, Distante M, Pellegrino S, Gatti S, Arrigo S, Civitelli F, Martelossi S; SIGENP IBD Working Group.

Inflamm Bowel Dis. 2016 Jul;22(7):1647-54. doi: 10.1097/MIB.0000000000000828.

PMID:
27271489
18.

Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis.

Turner D, Kolho KL, Mack DR, Raivio T, Leleiko N, Crandall W, Markowitz J, Silverberg MS, Jänne OA, Stempak J, Hyams J, Griffiths AM.

Inflamm Bowel Dis. 2010 Mar;16(3):469-73. doi: 10.1002/ibd.21070.

PMID:
19714760
19.

Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience.

Yamada S, Yoshino T, Matsuura M, Minami N, Toyonaga T, Honzawa Y, Tsuji Y, Nakase H.

BMC Gastroenterol. 2014 Apr 23;14:80. doi: 10.1186/1471-230X-14-80.

20.

Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.

Llaó J, Naves JE, Ruiz-Cerulla A, Gordillo J, Mañosa M, Maisterra S, Cabré E, Garcia-Planella E, Guardiola J, Domènech E.

Dig Liver Dis. 2016 Jun;48(6):608-12. doi: 10.1016/j.dld.2016.02.024. Epub 2016 Mar 5.

PMID:
27012443

Supplemental Content

Support Center